These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 7827348)
1. Rigorous management of insulin-dependent diabetes mellitus during pregnancy. Aucott SW; Williams TG; Hertz RH; Kalhan SC Acta Diabetol; 1994 Sep; 31(3):126-9. PubMed ID: 7827348 [TBL] [Abstract][Full Text] [Related]
2. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy. Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823 [TBL] [Abstract][Full Text] [Related]
3. [Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy]. Hiéronimus S; Cupelli C; Bongain A; Durand-Réville M; Berthier F; Fénichel P Gynecol Obstet Fertil; 2005 Jun; 33(6):389-94. PubMed ID: 15927506 [TBL] [Abstract][Full Text] [Related]
4. [The frequency of mild and severe fetal malformations in diabetic women with high values of glycosilated hemoglobin in early pregnancy]. Todorova K; Mazneĭkova V; Ivanov S; Genova M Akush Ginekol (Sofiia); 2005; 44(3):3-10. PubMed ID: 16028383 [TBL] [Abstract][Full Text] [Related]
5. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes. Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059 [TBL] [Abstract][Full Text] [Related]
6. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP). Feldberg D; Dicker D; Samuel N; Peleg D; Karp M; Goldman JA Acta Obstet Gynecol Scand; 1988; 67(4):333-8. PubMed ID: 3051881 [TBL] [Abstract][Full Text] [Related]
7. Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Howorka K; Pumprla J; Gabriel M; Feiks A; Schlusche C; Nowotny C; Schober E; Waldhoer T; Langer M Diabet Med; 2001 Dec; 18(12):965-72. PubMed ID: 11903395 [TBL] [Abstract][Full Text] [Related]
8. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Gabbe SG; Holing E; Temple P; Brown ZA Am J Obstet Gynecol; 2000 Jun; 182(6):1283-91. PubMed ID: 10871440 [TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Carta Q; Meriggi E; Trossarelli GF; Catella G; Dal Molin V; Menato G; Gagliardi L; Massobrio M; Vitelli A Diabete Metab; 1986 Jun; 12(3):121-9. PubMed ID: 3525266 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. Cypryk K; Sobczak M; Pertyńska-Marczewska M; Zawodniak-Szałapska M; Szymczak W; Wilczyński J; Lewiński A Med Sci Monit; 2004 Feb; 10(2):PI29-32. PubMed ID: 14737056 [TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus. Mantaj U; Gutaj P; Ozegowska K; Zawiejska A; Wroblewska-Seniuk K; Olejniczak D; Wender-Ozegowska E Ginekol Pol; 2019; 90(3):154-160. PubMed ID: 30950005 [TBL] [Abstract][Full Text] [Related]
13. Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers? Aydin Y; Berker D; Direktör N; Ustün I; Tütüncü YA; Işik S; Delibaşi T; Guler S Diabetes Res Clin Pract; 2008 Jun; 80(3):444-8. PubMed ID: 18359121 [TBL] [Abstract][Full Text] [Related]
14. A class of diabetes in mother, glycemic control in early pregnancy and occurrence of congenital malformations in newborn infants. Mironiuk M; Kietlińska Z; Jezierska-Kasprzyk K; Piekosz-Orzechowska B Clin Exp Obstet Gynecol; 1997; 24(4):193-7. PubMed ID: 9478316 [TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c. Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment. Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243 [TBL] [Abstract][Full Text] [Related]
17. Management of the insulin-dependent diabetic during labor and delivery. Influences on neonatal outcome. Miodovnik M; Mimouni F; Tsang RC; Skillman C; Siddiqi TA; Butler JB; Holroyde J Am J Perinatol; 1987 Apr; 4(2):106-14. PubMed ID: 3551973 [TBL] [Abstract][Full Text] [Related]
18. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes. Kekäläinen P; Juuti M; Walle T; Laatikainen T Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics of pre-gestational diabetes mellitus diagnosed during pregnancy and the effects on pregnancy outcomes]. Wei YM; Yang HX Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):227-232. PubMed ID: 28441837 [No Abstract] [Full Text] [Related] [Next] [New Search]